Aprea Therapeutics
APRE
APRE
39 hedge funds and large institutions have $25.6M invested in Aprea Therapeutics in 2021 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 12 increasing their positions, 9 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
22% less funds holding
Funds holding: 50 → 39 (-11)
61% less call options, than puts
Call options by funds: $599K | Put options by funds: $1.53M
65% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 17
Holders
39
Holding in Top 10
1
Calls
$599K
Puts
$1.53M
Top Buyers
| 1 | +$647K | |
| 2 | +$643K | |
| 3 | +$480K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$477K |
| 5 |
Goldman Sachs
New York
|
+$420K |
Top Sellers
| 1 | -$4.27M | |
| 2 | -$2.92M | |
| 3 | -$743K | |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$529K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$461K |